Bibliographic update on cell and protein engineering
DOI:
https://doi.org/10.56294/evk2026398Keywords:
Bioprocessing, Bioengineering, Monoclonal antibodies, Recombinant protein production, Mammalian cells, BioreactorsAbstract
Introduction: bioprocessing is undergoing a revolution driven by innovations such as single-use systems and continuous bioprocessing. The direct approach to cell engineering is to introduce to or omit from the cell a gene or genes by genetic engineering methods to endow a particular phenotype in order to improve the cellular processes. Over three-quarters of therapeutic proteins are produced using Chinese hamster ovary cells, that raises as the most common cell line used. The aim was to characterize cell and protein engineering.
Methods: a literature review was conducted, where 18 articles in English and Spanish were selected, published in the last five years on the subject, in databases such as: Scopus, PubMed, Springer.
Results: deleting nonessential genes may increase the productivity by directing cellular resources toward product biosynthesis. Cell culture system provide controlled environments to study cellular process, mammalian cell cultures are valuable for virology, vaccine production, tissue regeneration, genetic engineering. The use of these modified cells is essential for producing recombinant proteins, antibodies and vaccines.
Conclusions: cell and protein engineering raised as alternative tools for the development of specific therapies in cancer and immunologic diseases in the last few years. Recombinant protein production lay on areas as cell culture, mammalian cells for specific antibody expression, cell culture technologies and bioreactors as the corner stone for bioprocess.
References
1. Bandyopadhyay AA, Khetan A, Malmberg L-H, Zhou W, Hu W-S. Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics. Journal of Industrial Microbiology and Biotechnology 2017;44:785–97. https://doi.org/10.1007/s10295-017-1913-4. DOI: https://doi.org/10.1007/s10295-017-1913-4
2. Kuystermans D, Krampe B, Swiderek H, Al-Rubeai M. Using cell engineering and omic tools for the improvement of cell culture processes. Cytotechnology 2007;53:3–22. https://doi.org/10.1007/s10616-007-9055-6. DOI: https://doi.org/10.1007/s10616-007-9055-6
3. Hu W. Cell Culture Bioprocesses and Biomanufacturing, 2017, p. 289–318. https://doi.org/10.1002/9781119159056.ch10. DOI: https://doi.org/10.1002/9781119159056.ch10
4. Malathi H, Singh SK, Narayan J. Investigating the Role of Decellularization in Liver Regeneration and Scaffold Development for Transplantation. Seminars in Medical Writing and Education 2023;2:143. https://doi.org/10.56294/mw2023143. DOI: https://doi.org/10.56294/mw2023143
5. Yodsanga S, Poeaim S, Chantarangsu S, Swasdison S. Investigation of Biodegradation and Biocompatibility of Chitosan–Bacterial Cellulose Composite Scaffold for Bone Tissue Engineering Applications. Cells 2025;14. https://doi.org/10.3390/cells14100723. DOI: https://doi.org/10.20944/preprints202502.1787.v1
6. O’Brien SA, Hu W-S. Cell culture bioprocessing — the road taken and the path forward. Current Opinion in Chemical Engineering 2020;30:128–34. https://doi.org/10.1016/j.coche.2020.100663. DOI: https://doi.org/10.1016/j.coche.2020.100663
7. Tripathi NK, Shrivastava A. Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development. Front Bioeng Biotechnol 2019;7:420. https://doi.org/10.3389/fbioe.2019.00420. DOI: https://doi.org/10.3389/fbioe.2019.00420
8. Reyes SJ, Durocher Y, Pham PL, Henry O. Modern Sensor Tools and Techniques for Monitoring, Controlling, and Improving Cell Culture Processes. Processes 2022;10. https://doi.org/10.3390/pr10020189. DOI: https://doi.org/10.3390/pr10020189
9. Ozturk SS. Engineering challenges in high density cell culture systems. Cytotechnology 1996;22:3–16. https://doi.org/10.1007/BF00353919. DOI: https://doi.org/10.1007/BF00353919
10. Papantoniou I, Lambrechts T, Aerts MJ. Bioprocess engineering strategies for autologous human MSC-based therapies: one size does not fit all. Cell Gene Therapy Insights 2017;3:469–82. https://doi.org/10.18609/cgti.2017.040. DOI: https://doi.org/10.18609/cgti.2017.040
11. Das C, S RJ, Rohini. Adaptive Control Strategies for Bioprinting Tissues and Organs in Biomedical Engineering Applications. Seminars in Medical Writing and Education 2023;2:100. https://doi.org/10.56294/mw2023100. DOI: https://doi.org/10.56294/mw2023100
12. Horta-Martínez LE. 3D printing in the medical field. Seminars in Medical Writing and Education 2022;1:8. https://doi.org/10.56294/mw20228. DOI: https://doi.org/10.56294/mw20228
13. Reger LN, Saballus M, Matuszczyk J, Kampmann M, Wijffels RH, Martens DE, et al. Boosting Productivity for Advanced Biomanufacturing by Re-Using Viable Cells. Frontiers in Bioengineering and Biotechnology 2023;Volume 11-2023. DOI: https://doi.org/10.3389/fbioe.2023.1106292
14. Bhardwaj U, Samal P, Malathi H. Stem Cell-Based Cartilage Engineering Approaches for Osteochondral Defect Regeneration and Functional Tissue Repair. Seminars in Medical Writing and Education 2023;2:148. https://doi.org/10.56294/mw2023148. DOI: https://doi.org/10.56294/mw2023148
15. Pereira S, Coutinho D, Matos A, Silva W, Fabrino D. Three-dimensional cell culture, opportunities and challenges for bioprocess engineers. Brazilian Journal of Biological Sciences 2016;3:263–77. https://doi.org/10.21472/bjbs.030603. DOI: https://doi.org/10.21472/bjbs.030603
16. Palladino F, Marcelino PR, Schlogl AE, José ÁH, Rodrigues RD, Fabrino DL, et al. Bioreactors: Applications and Innovations for a Sustainable and Healthy Future—A Critical Review. Applied Sciences 2024;14. https://doi.org/10.3390/app14209346. DOI: https://doi.org/10.3390/app14209346
17. Sharma R, Harrison S, Tai S. Advances in Bioreactor Systems for the Production of Biologicals in Mammalian Cells. ChemBioEng Reviews 2021;9. https://doi.org/10.1002/cben.202100022. DOI: https://doi.org/10.1002/cben.202100022
18. Kaya U. Advancements in Bioreactors: Revolutionizing bioprocessing Technologies. Pharmaceutical Bioprocessing 2023;11:120–1. https://doi.org/10.37532/20489145.2023.11.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Telmo Raul Aveiro-Róbalo, Vanessa Pérez-Del-Vallín (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
